On Thursday, the U.S. Food & Drug Administration announced that the single-dose Johnson & Johnson Covid-19 vaccine shelf life has been extended from four and a half months to six. This announcement comes as several officials have expressed concern about the possibility of vaccine doses going bad or expiring.
The Key Facts
Johnson & Johnson released a statement saying that the FDA made the decision based upon data from ongoing research showing the vaccine is stable when kept at 36 to 46 degrees F.
The FDA sent a note to the company stating that they will extend the validity of batches that may have expired before the order was issued, as long as the batch is kept at the required temperature.
This company will make it possible for vaccine suppliers to use its website as a reference point, updating the expiry dates on their batches.
This move will give health professionals six more weeks to distribute millions of vaccine doses.
The FDA previously increased the shelf life of J&J vaccine from 3 months to 4 months, in June.
49.3% This is the U.S. total Covid-19 vaccination rate, as reported by the Centers for Disease Control and Prevention. The average American adult has received at least one dose.
J&J’s vaccine can be kept at normal temperatures and administered in one shot, unlike the two mRNA Covid-19 vaccinations (made by Moderna or Pfizer). The vaccine is easy to transport and administer in remote areas and rural areas where there may not be enough healthcare infrastructure. The CDC estimates that more than 13,000,000 people have been given the vaccine in the United States. Comparatively, over 87 million people received two doses from Pfizer and 63 millions received Modera.
The US increases the expiration date for J&J COVID vaccine by 6 months (Associated Press).
J&J: U.S. FDA accepts an extension of shelf life for its COVID-19 vaccine
F.D.A. extends J&J vaccine shelf-life to six months (New York Times).
Publited at Thu 29 July 2021, 05:25.21 (+0000).